Clinical Trial Update: Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma [Phase 4]

View source ↗

Summary

Open randomized prospective Phase 4 trial comparing R-FPD to R-MAD in primary CNS lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• R-FPD
• R-MAD

Snippet

Sponsor: Mingzhi Zhang | Conditions: Primary Central Nervous System Lymphoma | Phase 4 | Status: UNKNOWN